Unibest 优贝德
← Back to patent-cliff list

普托马尼

Tier C — Watch / trade

Pretomanid

诺华制药
Originator
2019
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type

TargetsDNA

BrandPretomanid FGK

Indications (approved)结核分枝杆菌感染、耐多药肺结核

Regional status

US
批准上市
2019-08-14
EU
批准上市
2020-07-31
China
批准上市
2024-12-01
Japan
-

Synthetic routes & intermediates2 routes

Originator routes × 1Optimised (non-patent) × 1Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 5 · Total yield 0.49 g (Pretomanid)
Synthetic routes & intermediates Route 1
CodeCAS No.Intermediate
PRET-0015213-49-02,4-dinitro-1H-imidazole
PRET-002123237-62-7(S)-tert-butyldimethyl(oxiran-2-ylmethoxy)silane
PRET-003187235-04-7(S)-1-((tert-butyldimethylsilyl)oxy)-3-(2,4-dinitro-1H-imidazol-1-yl)propan-2-ol
PRET-004187235-73-01-((2S)-3-((tert-butyldimethylsilyl)oxy)-2-((tetrahydro-2H-pyran-2-yl)oxy)propyl)-2,4-dinitro-1H-imidazole
PRET-005187235-06-9(6S)-2-nitro-6-((tetrahydro-2H-pyran-2-yl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
PRET-006187235-08-1(S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol
PRET-00750824-05-01-(bromomethyl)-4-(trifluoromethoxy)benzene
OptimisedRoute 2Steps 8 · Total yield 13.33 g (Pretomanid)
Synthetic routes & intermediates Route 2
CodeCAS No.Intermediate
PRET-0015213-49-02,4-dinitro-1H-imidazole
PRET-005187235-06-9(6S)-2-nitro-6-((tetrahydro-2H-pyran-2-yl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
PRET-006187235-08-1(S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol
PRET-00750824-05-01-(bromomethyl)-4-(trifluoromethoxy)benzene
PRET-008288-32-41H-imidazole
PRET-0093034-38-64-nitro-1H-imidazole
PRET-01019182-81-11,4-dinitro-1H-imidazole
PRET-01165031-96-1(S)-oxiran-2-ylmethyl butyrate
PRET-0121258937-18-6(S)-3-(2,4-dinitro-1H-imidazol-1-yl)-2-hydroxypropyl butyrate
PRET-0131258937-19-7(2S)-3-(2,4-dinitro-1H-imidazol-1-yl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propyl butyrate

Frequently asked questions

What are the approved indications of Pretomanid?

Approved indications include: 结核分枝杆菌感染, 耐多药肺结核.

When does the Pretomanid patent expire?

No public expiry year is available for Pretomanid yet; this page updates once verified.

How many synthesis routes are recorded for Pretomanid?

2 synthesis routes are recorded; the shortest is 5 steps with 0.49 g (Pretomanid) total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Pretomanid intermediates?

All intermediates in Pretomanid routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Pretomanid intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-24